Discover

COCP
Cocrystal Pharma, Inc.
1.07
2 x 0.82
2 x 1.49
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
1.08 +0.01 (0.93%)
Ytd9.18%
1y-12.30%
1.06
day range
1.07
0.82
52 week range
1.57
Open1.06Prev Close1.07Low1.06High1.07Mkt Cap20.61M
Vol4.26KAvg Vol56.00KEPS-0.76P/EN/AForward P/E-1.22
Beta1.45Short Ratio0.12Inst. Own6.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg1.12200-d Avg1.111yr Est8.00
Income Statement
Operating Expenses3.29M
Research and Development Expense2.14M
Selling, General and Administrative Expense1.15M
Operating Income-3.29M
Net Income-3.16M
Net Income Common Stock-3.16M
Net Income Common Stock (USD)-3.16M
Consolidated Income-3.16M
Earnings per Basic Share-0.23
Earnings per Basic Share (USD)-0.23
Earnings per Diluted Share-0.23
Earning Before Interest & Taxes (EBIT)-3.16M
Earning Before Interest & Taxes (USD)-3.16M
Weighted Average Shares13.79M
Weighted Average Shares Diluted13.79M
Balance Sheet
Cash and Equivalents2.36M
Cash and Equivalents (USD)2.36M
Current Assets3.24M
Property, Plant & Equipment Net1.30M
Total Assets4.65M
Debt Current352.00K
Total Debt1.34M
Current Liabilities2.62M
Debt Non-Current989.00K
Total Liabilities3.61M
Accumulated Retained Earnings (Deficit)-347.71M
Shareholders Equity1.04M
Shareholders Equity (USD)1.04M
Assets Non-Current1.41M
Total Debt (USD)1.34M
Liabilities Non-Current989.00K
Trade and Non-Trade Payables2.26M
Tax Assets701.00K
Cash Flow
Depreciation, Amortization & Accretion12.00K
Net Cash Flow / Change in Cash & Cash Equivalents-2.52M
Net Cash Flow from Operations-2.52M
Share Based Compensation92.00K